These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

872 related items for PubMed ID: 29720976

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Non-Modified CpG Oligodeoxynucleotide Forming Guanine-Quadruplex Structure Complexes with ε-Poly-L-Lysine Induce Antibody Production as Vaccine Adjuvants.
    Zhao D, Tu ATT, Shobo M, Le NBT, Yoshikawa C, Sugai K, Hakamata Y, Yamazaki T.
    Biomolecules; 2022 Dec 13; 12(12):. PubMed ID: 36551297
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Double-stranded phosphodiester cytosine-guanine oligodeoxynucleotide complexed with calcium phosphate as a potent vaccine adjuvant for activating cellular and Th1-type humoral immunities.
    Hanagata N, Li X, Chen MH, Li J, Hattori S.
    Int J Nanomedicine; 2018 Dec 13; 13():43-62. PubMed ID: 29317815
    [Abstract] [Full Text] [Related]

  • 7. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R, Muto S, Iwata T, Hidaka A, Kiyono H, Kunisawa J, Aramaki Y.
    BMC Res Notes; 2017 Jan 26; 10(1):68. PubMed ID: 28126014
    [Abstract] [Full Text] [Related]

  • 8. Induction of a balanced Th1/Th2 immune responses by co-delivery of PLGA/ovalbumin nanospheres and CpG ODNs/PEI-SWCNT nanoparticles as TLR9 agonist in BALB/c mice.
    Ebrahimian M, Hashemi M, Maleki M, Abnous K, Hashemitabar G, Ramezani M, Haghparast A.
    Int J Pharm; 2016 Dec 30; 515(1-2):708-720. PubMed ID: 27989827
    [Abstract] [Full Text] [Related]

  • 9. Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN.
    Singh SM, Alkie TN, Abdelaziz KT, Hodgins DC, Novy A, Nagy É, Sharif S.
    Viral Immunol; 2016 Jun 30; 29(5):269-75. PubMed ID: 27077969
    [Abstract] [Full Text] [Related]

  • 10. Cytosine-phosphate-guanine oligodeoxynucleotides containing GACGTT motifs enhance the immune responses elicited by keyhole limpet hemocyanin antigen in dairy cattle.
    Chu CY, Lee SC, Liu SS, Lin YM, Shen PC, Yu C, Lee KH, Zhao X, Lee JW.
    Nucleic Acid Ther; 2011 Oct 30; 21(5):323-32. PubMed ID: 21916610
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications.
    Becker Y.
    Virus Genes; 2005 Mar 30; 30(2):251-66. PubMed ID: 15744581
    [Abstract] [Full Text] [Related]

  • 15. An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen.
    Wakita D, Chamoto K, Zhang Y, Narita Y, Noguchi D, Ohnishi H, Iguchi T, Sakai T, Ikeda H, Nishimura T.
    Int Immunol; 2006 Mar 30; 18(3):425-34. PubMed ID: 16415100
    [Abstract] [Full Text] [Related]

  • 16. Multiple effects of immunostimulatory DNA on T cells and the role of type I interferons.
    Sun S, Zhang X, Tough D, Sprent J.
    Springer Semin Immunopathol; 2000 Mar 30; 22(1-2):77-84. PubMed ID: 10944802
    [Abstract] [Full Text] [Related]

  • 17. Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery.
    Diwan M, Elamanchili P, Cao M, Samuel J.
    Curr Drug Deliv; 2004 Oct 30; 1(4):405-12. PubMed ID: 16305402
    [Abstract] [Full Text] [Related]

  • 18. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.
    Mochizuki S, Morishita H, Kobiyama K, Aoshi T, Ishii KJ, Sakurai K.
    J Control Release; 2015 Dec 28; 220(Pt A):495-502. PubMed ID: 26562685
    [Abstract] [Full Text] [Related]

  • 19. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
    Jin JW, Tang SQ, Rong MZ, Zhang MQ.
    Acta Biomater; 2018 Sep 15; 78():211-223. PubMed ID: 30098441
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.